TCMD - Rasio utang marang kapitalisasi buku tactilemedical.com

Logo korporat perusahaan Tactile Systems Technology Inc. (TCMD)

Risks for Tactile Systems Technology (TCMD) are linked to the revision of Medicare payments and sales staff costs, with the metric standing at 0.06. The price action chart reflects the dynamics of the lymphedema systems manufacturer's shares. Stability is ensured by partnerships with numerous insurance companies and clinics. Despite its narrow specialization, Tactile Systems Technology (TCMD) leads the US market, generating revenue from the regular sale of ancillary materials.

Tactile Systems Technology, Inc. - Utang-utang marang kapitalisasi buku TCMD (periode 04.07.2022 - 27.10.2026)
Barang unggulan Tactile Systems Technology, Inc.

This indicator reflects the proportion of borrowed funds relative to the value of net assets, allowing a conservative investor to assess the real financial stability and the degree of the business's dependence on creditors. By analyzing the dynamics of debt obligations to balance sheet capital, one can determine the margin of safety for Tactile Systems Technology (TCMD) given that revenue depends on insurance company decisions regarding the reimbursement of lymphedema therapy costs.

Pesaing Tactile Systems Technology

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku NeuroPace, Inc. NPCE|SNWV - Utang marang modal buku|Outset Medical - Utang-utang marang kapitalisasi buku|Electromed (ELMD) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku LNSR|Utang marang nilai buku AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Utang marang nilai buku|Rasio utang marang aset resik BDMD (bairdmed.com)|EDAP TMS - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Utang-utang marang kapitalisasi buku|LUNG - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku telabio.com|CytoSorbents Corporation (CTSO) - Rasio utang marang nilai buku|SRTS: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Zynex Medical|Utang-utang marang kapitalisasi buku ECOR (electroCore, Inc.)|Utang marang nilai buku vicarioussurgical.com (RBOT)|Utang-utang marang kapitalisasi buku IINN (Inspira Technologies)|seastarmedical.com - Utang-utang marang kapitalisasi buku|IRIX - Rasio utang marang kapitalisasi buku|Intelligent Bio Solutions (INBS) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku beyondair.net XAIR|Profusa, Inc (PFSA) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SSKN (STRATA Skin Sciences Inc.)|Utang-utang marang nilai buku GCTK|NAOV: Rasio utang marang kapitalisasi buku|Utang marang aset resik Venus Concept Inc VERO|Utang marang nilai buku NUWE (CHF Solutions)|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|Utang-utang marang kapitalisasi buku ASXC (TransEnterix)|AVGR: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku